This paper is in the following e-collection/theme issue:

RCTs - Protocols/Proposals (non-eHealth) (291) Infectious Diseases (non-STD/STI) (1478)

Published on in Vol 12 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/41197, first published .
Repeat Ivermectin Mass Drug Administrations for Malaria Control II: Protocol for a Double-blind, Cluster-Randomized, Placebo-Controlled Trial for the Integrated Control of Malaria

Repeat Ivermectin Mass Drug Administrations for Malaria Control II: Protocol for a Double-blind, Cluster-Randomized, Placebo-Controlled Trial for the Integrated Control of Malaria

Repeat Ivermectin Mass Drug Administrations for Malaria Control II: Protocol for a Double-blind, Cluster-Randomized, Placebo-Controlled Trial for the Integrated Control of Malaria

Authors of this article:

Brian D Foy1 Author Orcid Image ;   Anthony Some2 Author Orcid Image ;   Tereza Magalhaes3, 4 Author Orcid Image ;   Lyndsey Gray1 Author Orcid Image ;   Sangeeta Rao5 Author Orcid Image ;   Emmanuel Sougue2 Author Orcid Image ;   Conner L Jackson6 Author Orcid Image ;   John Kittelson6 Author Orcid Image ;   Hannah C Slater7 Author Orcid Image ;   Teun Bousema8 Author Orcid Image ;   Ollo Da2 Author Orcid Image ;   A Gafar V Coulidiaty2 Author Orcid Image ;   McKenzie Colt9 Author Orcid Image ;   Martina Wade9 Author Orcid Image ;   Kacey Richards9 Author Orcid Image ;   A Fabrice Some2 Author Orcid Image ;   Roch K Dabire2 Author Orcid Image ;   Sunil Parikh9 Author Orcid Image
Article Authors Cited by (1) Tweetations (18) Metrics

Journals

  1. Kaur B, Blavo C, Parmar M. Ivermectin: A Multifaceted Drug With a Potential Beyond Anti-parasitic Therapy. Cureus 2024 View